Evidence map›Paper›PMID 40170189›Full record

ArticlePilot and feasibility studies2025

A pilot randomized controlled double-blind trial of intermittent theta burst stimulation (iTBS) repetitive transcranial magnetic stimulation (rTMS) to improve memory in mild cognitive impairment (MCI): a study protocol.

Maria I Lapid, Sandeep R Pagali, Michael R Basso, Paul E Croarkin, Jennifer R Geske, John Huston, Karimul Islam, Boney Joseph, Walter W Kennebeck, Daehun Kang and 14 more

Registry-linked trialAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05327257 (A Feasibility and Pilot Randomized Controlled Double-blind Trial of Intermittent Theta Burst Stimulation), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05327257 nacompletednot on this map

A Feasibility and Pilot Randomized Controlled Double-blind Trial of Intermittent Theta Burst Stimulation (iTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Memory in Mild Cognitive Impairment (MCI)

TypeinterventionalSponsorMaria I. Lapid, M.D.Ran2022 to 2025Enrolled25ConditionsMild Cognitive ImpairmentArmsiTBS rTMS
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Effects of accelerated intermittent theta-burst stimulation combined with cognitive training on brain function in amnestic mild cognitive impairment patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maria I LapidDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. lapid.maria@mayo.edu.ORCID http://orcid.org/0000-0002-1163-5584
Sandeep R PagaliDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Michael R BassoDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Jennifer R GeskeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
John HustonDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Karimul IslamDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Boney JosephDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Walter W KennebeckDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Daehun KangDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Simon KungDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Allison M LeMahieuDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Brian N LundstromDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Mikaela M SarranDepartment of Medicine Research, Mayo Clinic, Rochester, MN, USA.
Yunhong ShuDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Ilya M SwansonDepartment of Medicine Research, Mayo Clinic, Rochester, MN, USA.
Erik K St LouisDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Melissa K WangDepartment of Medicine Research, Mayo Clinic, Rochester, MN, USA.
Yogatheesan VaratharajahDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Neeraj WaghDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Kirk M WelkerDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Gregory A WorrellDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMild cognitive impairment (MCI), prevalent among older adults, often precedes Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD), emphasizing the need for effective interventions. Early intervention in MCI is crucial, not only to alleviate symptoms but to potentially delay the progression of cognitive decline. The lack of definitive treatments for MCI has prompted the exploration into alternative non-pharmacological therapeutic approaches. Specifically, noninvasive brain stimulation using repetitive transcranial magnetic stimulation (rTMS) has demonstrated promise in improving cognition in MCI and AD.

objectivesOur study will test the feasibility of using intermittent theta burst stimulation (iTBS) technique of rTMS in MCI, pilot test the study design, and collect pilot data on the effect of iTBS over three different brain regions on working memory, new learning, and executive function in MCI. Exploratory objectives are to assess the feasibility and usefulness of functional magnetic resonance imaging (fMRI), high-density electroencephalography (HD-EEG), and sleep architecture as potential biomarkers in response to iTBS.

methodsA pilot randomized double-blind controlled cross-over trial of iTBS on 20 MCI participants randomized to 10 days of active iTBS (left dorsolateral prefrontal cortex or left lateral parietal cortex) or control (vertex). After 4-6-week washout period, they cross over to the alternative treatment arm for another 10 days. Each participant will undergo a total of 20 iTBS sessions. Pre- and post-iTBS assessments include neuropsychological tests, fMRI, HD-EEG, and sleep architecture. DISCUSSION: This innovative study aims to test the feasibility of iTBS as a cognitive enhancement strategy in MCI. If our study is feasible, it could lead to a future larger trial to further test whether iTBS can modulate underlying neurobiology and offer a therapeutic avenue to remediate cognitive decline in MCI or ultimately delay progression to dementia.

trial registrationClinicalTrials.gov, NCT05327257. Registered 04 April 2022.

Indexed as

Alzheimer’sBrain disorderCognitive declineCognitive enhancementDementiaGeriatricsMemory disorderNeurologyNeuromodulationNoninvasive brain stimulation

Identifiers

PMID40170189
PMCPMC11963328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.